Clinical Trials Logo

Clinical Trial Summary

The investigators intended for this study to deliver the "proof-of-concept" that locally administered pilocarpine drops in two doses are effective in a population of elderly (aged ≥ 70 years) with xerostomia at the expense of limited adverse events. To this end, the study aims to quantify the effect size of pilocarpine in two different dosages. In case the investigators observe clinically meaningful changes in xerostomia through measured NRS, a sufficiently-powered RCT will be prepared to compare pilocarpine to placebo.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Patients of Advanced Age (= 70 Years) With a Clinical Diagnosis of Chronic Dry Mouth
  • Xerostomia

NCT number NCT04195100
Study type Interventional
Source Maastricht University Medical Center
Contact
Status Completed
Phase Early Phase 1
Start date April 1, 2019
Completion date January 31, 2020